These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29194189)

  • 1. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
    Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR
    Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yolk sac tumor of the ovary: a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit (TGCU).
    Kojimahara T; Nakahara K; Takano T; Yaegashi N; Nishiyama H; Fujimori K; Sato N; Terada Y; Tase T; Yokoyama Y; Mizunuma H; Shoji T; Sugiyama T; Kurachi H
    Tohoku J Exp Med; 2013 Aug; 230(4):211-7. PubMed ID: 23912096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
    Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
    J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
    Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
    Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
    Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
    Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
    Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
    Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Characterization of a Novel Primitive Yolk Sac Tumour Cell Line, TC587.
    Iwasaki T; Kohashi K; Ohno M; Taguchi T; Oda Y
    Anticancer Res; 2020 Feb; 40(2):759-766. PubMed ID: 32014918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian yolk sac tumor in postmenopausal females: a report of five cases and a literature review.
    Wang X; He J; Li Y
    Eur J Gynaecol Oncol; 2016; 37(3):374-9. PubMed ID: 27352567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.